Development of a novel hemophilia A mouse model to study emicizumab and factor VIII inhibitor risk.

Saved in:
Bibliographic Details
Title: Development of a novel hemophilia A mouse model to study emicizumab and factor VIII inhibitor risk.
Authors: Chou SC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Chang YT; Department of Clinical Laboratory Science and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan., Chen LF; Department of Clinical Laboratory Science and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan., Tsai CH; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Cheng CY; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Sun CP; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan., Tao MH; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan., Hong CL; Department of Clinical Laboratory Science and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan., Wu HL; Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Lin SW; Department of Clinical Laboratory Science and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Source: Blood advances [Blood Adv] 2026 May 12; Vol. 10 (9), pp. 3118-3127.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2025018691